Searched for
EPILEPSY DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Pakistan: Severe shortage of life-saving drugs in Karachi worries patients, citizensKarachi in Pakistan is facing a severe shortage of essential medicines, including life-saving drugs, causing concern for patients and citiz...
- Stigma and missed moments, the mental health cost of living with epilepsyIn India, nearly 60 lakh people have epilepsy.
- Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...
- Natco Pharma launches epilepsy treatment drug Brivaracetam in IndiaThe company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing.
- Sun Pharma to launch complete range of generic anti-epilepsy drugThe drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solut...
- JB Chemicals gets USFDA nod to market generic epilepsy drugJB Chemicals and Pharmaceuticals on Monday said it has received approval from the US health regulator to market Carbamazepine extended rele...
- Made-in-India drugs to be based on weed soonThe move to produce medicine formulations that incorporate hemp lend a fresh reputation to the otherwise controversial cannabis
- Planned pregnancy can help 90% epileptic women have healthy babiesNew Delhi, Nov 19 (IANS) Planned pregnancy can help 90 per cent of epileptic women deliver healthy babies, said doctors.
- FDA approves first 3D-printed drugIn a world first, the US has approved a 3D-printed drug to treat certain types of seizures in epilepsy patients.
- Advanced Epilepsy Neurobiology lab set up"Epilepsy is a result of hundreds of brain cells producing abnormally high levels of electricity, which results in different manifestations.
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Sun Pharma recalls 3,263 bottles of epilepsy drug in USAs per the information available, Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing "dissolution spe...
- Delhi High Court comes to Intas rescue, stops Arinna Lifescience for trademark violationDelhi High Court gave relief to Ahmedabad-based drug maker, Intas Pharmaceuticals, by granting an ex-parte injunction against the sale of V...
- Lupin gets final US FDA nod for generic anti-epileptic drugLupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.
- Ranbaxy, Aurobindo get US FDA nod for epilepsy drugPharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.
- US drug agency warns of suicide risk with epilepsy drugsEpilepsy drugs used by millions may increase the risk of suicidal thoughts or behavior, US regulators have warned.
Load More
